SIA
EUCRU

Schechter Investment Advisors’s Eucrates Biomedical Acquisition Corp. Unit EUCRU Stock Holding History

Schechter Investment Advisors’s Portfolio EUCRU Stock Details EUCRU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-79,060
Closed -$792K – 969
2022
Q3 		$792K Buy
79,060
+2,418
+3% +$24.1K 0.08% 358
2022
Q2 		$759K Sell
76,642
-6,160
-7% -$61.2K 0.07% 378
2022
Q1 		$816K Sell
82,802
-4,590
-5% -$45.5K 0.08% 379
2021
Q4 		$872K Buy
+87,392
New +$878K 0.08% 353

Other funds holding EUCRU

Verition Fund Management
Verition Fund Management Greenwich, Connecticut $10.3B AUM 30.69% 1-Year Est. Return
SCM
Sio Capital Management New York $694M AUM 79.73% 1-Year Est. Return
WAM
Wolverine Asset Management Chicago, Illinois $6.41B AUM 4.78% 1-Year Est. Return
CS
Clear Street New York $17.8B AUM 56.26% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $564B AUM 30.12% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return